Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California

Samuel Oschin Comprehensive Cancer Institute is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Samuel Oschin Comprehensive Cancer Institute has participated in 3 clinical trials.

Therapeutic areas: Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Carcinoma, Advanced Solid Tumors.

Sponsors: ImmunityBio, Inc., Halozyme Therapeutics.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Samuel Oschin Comprehensive Cancer Institute?

Samuel Oschin Comprehensive Cancer Institute has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Samuel Oschin Comprehensive Cancer Institute conducted?

Samuel Oschin Comprehensive Cancer Institute has 3 clinical trials on record. Their work covers Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Carcinoma, Advanced Solid Tumors.

Is Samuel Oschin Comprehensive Cancer Institute accredited by Crixeo Health?

Samuel Oschin Comprehensive Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Samuel Oschin Comprehensive Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.